131 related articles for article (PubMed ID: 24603981)
1. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis.
Toshima T; Shirabe K; Ikegami T; Yoshizumi T; Kuno A; Togayachi A; Gotoh M; Narimatsu H; Korenaga M; Mizokami M; Nishie A; Aishima S; Maehara Y
J Gastroenterol; 2015 Jan; 50(1):76-84. PubMed ID: 24603981
[TBL] [Abstract][Full Text] [Related]
2. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
Heo JY; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YN; Ahn SS; Han KH; Kim HS
Medicine (Baltimore); 2016 Apr; 95(14):e3328. PubMed ID: 27057911
[TBL] [Abstract][Full Text] [Related]
3. Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis.
Nagakawa K; Hidaka M; Hara T; Matsushima H; Imamura H; Tanaka T; Adachi T; Soyama A; Kanetaka K; Eguchi S
PLoS One; 2023; 18(11):e0293593. PubMed ID: 37910585
[TBL] [Abstract][Full Text] [Related]
4. A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.
Kuno A; Ikehara Y; Tanaka Y; Ito K; Matsuda A; Sekiya S; Hige S; Sakamoto M; Kage M; Mizokami M; Narimatsu H
Sci Rep; 2013; 3():1065. PubMed ID: 23323209
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
Yamasaki K; Tateyama M; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Sasaki R; Bekki S; Kugiyama Y; Miyazoe Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Yatsuhashi H
Hepatology; 2014 Nov; 60(5):1563-70. PubMed ID: 25042054
[TBL] [Abstract][Full Text] [Related]
6. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease.
Abe M; Miyake T; Kuno A; Imai Y; Sawai Y; Hino K; Hara Y; Hige S; Sakamoto M; Yamada G; Kage M; Korenaga M; Hiasa Y; Mizokami M; Narimatsu H
J Gastroenterol; 2015 Jul; 50(7):776-84. PubMed ID: 25326152
[TBL] [Abstract][Full Text] [Related]
7. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Umemura T; Joshita S; Sekiguchi T; Usami Y; Shibata S; Kimura T; Komatsu M; Matsumoto A; Ota M; Tanaka E
Am J Gastroenterol; 2015 Jun; 110(6):857-64. PubMed ID: 25916223
[TBL] [Abstract][Full Text] [Related]
8. Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients.
Tamaki N; Kurosaki M; Kuno A; Korenaga M; Togayachi A; Gotoh M; Nakakuki N; Takada H; Matsuda S; Hattori N; Yasui Y; Suzuki S; Hosokawa T; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Mizokami M; Narimatsu H; Izumi N
Hepatol Res; 2015 Oct; 45(10):E82-8. PubMed ID: 25559682
[TBL] [Abstract][Full Text] [Related]
9. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis.
Hanai T; Shiraki M; Ohnishi S; Miyazaki T; Ideta T; Kochi T; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
Hepatol Res; 2015 Nov; 45(11):1083-90. PubMed ID: 25565570
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
[TBL] [Abstract][Full Text] [Related]
11. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.
Ura K; Furusyo N; Ogawa E; Hayashi T; Mukae H; Shimizu M; Toyoda K; Murata M; Hayashi J
Aliment Pharmacol Ther; 2016 Jan; 43(1):114-24. PubMed ID: 26503582
[TBL] [Abstract][Full Text] [Related]
12. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics.
Narimatsu H
Expert Rev Proteomics; 2015; 12(6):683-93. PubMed ID: 26394846
[TBL] [Abstract][Full Text] [Related]
13. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.
Shirabe K; Bekki Y; Gantumur D; Araki K; Ishii N; Kuno A; Narimatsu H; Mizokami M
J Gastroenterol; 2018 Jul; 53(7):819-826. PubMed ID: 29318378
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.
Uojima H; Yamasaki K; Sugiyama M; Kage M; Ishii N; Shirabe K; Hidaka H; Kusano C; Murakawa M; Asahina Y; Nishimura T; Iijima H; Sakamoto K; Ito K; Amano K; Kawaguchi T; Tamaki N; Kurosaki M; Suzuki T; Matsuura K; Taketomi A; Joshita S; Umemura T; Nishina S; Hino K; Toyoda H; Yatsuhashi H; Mizokami M
J Gastroenterol; 2024 Apr; ():. PubMed ID: 38625546
[TBL] [Abstract][Full Text] [Related]
15. Current status of preoperative risk assessment for posthepatectomy liver failure in patients with hepatocellular carcinoma.
Nishio T; Taura K; Koyama Y; Ishii T; Hatano E
Ann Gastroenterol Surg; 2023 Nov; 7(6):871-886. PubMed ID: 37927928
[TBL] [Abstract][Full Text] [Related]
16. New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease.
Uojima H; Nakabayashi K; Yamasaki K; Sugiyama M; Ishii N; Shirabe K; Kyoutou T; Ueda K; Takahama Y; Tamaki N; Kurosaki M; Hidaka H; Kusano C; Amano K; Kawaguchi T; Taketomi A; Joshita S; Umemura T; Murakawa M; Asahina Y; Suzuki T; Matsuura K; Nishimura T; Iijima H; Sakamoto K; Ito K; Nishina S; Hino K; Toyoda H; Yatsuhashi H; Kage M; Mizokami M
J Gastroenterol; 2023 Dec; 58(12):1252-1260. PubMed ID: 37812281
[TBL] [Abstract][Full Text] [Related]
17. The Natural History and Management of Hepatic Hemangioma.
Maruyama S; Matono T; Koda M
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685768
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Characteristics of Hepatic Hemangioma Associated with Coagulopathy and Its Predictive Risk Factors.
Maruyama S; Matono T; Koda M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35893437
[TBL] [Abstract][Full Text] [Related]
19. The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C.
Tajiri H; Suzuki M; Bessho K; Ito Y; Murakami J; Hatori R; Takano T; Miyoshi Y; Brooks S
Sci Rep; 2022 Jul; 12(1):11205. PubMed ID: 35778417
[TBL] [Abstract][Full Text] [Related]
20. Development and Evaluation of a Robust Sandwich Immunoassay System Detecting Serum WFA-Reactive IgA1 for Diagnosis of IgA Nephropathy.
Uenoyama Y; Matsuda A; Ohashi K; Ueda K; Yokoyama M; Kyoutou T; Kishi K; Takahama Y; Nagai M; Ohbayashi T; Hotta O; Matsuzaki H
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
